414 related articles for article (PubMed ID: 32502542)
21. Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.
Cure E; Cumhur Cure M; Vatansev H
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972015. PubMed ID: 33169637
[No Abstract] [Full Text] [Related]
22. Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression.
Bohn MK; Hall A; Sepiashvili L; Jung B; Steele S; Adeli K
Physiology (Bethesda); 2020 Sep; 35(5):288-301. PubMed ID: 32783610
[TBL] [Abstract][Full Text] [Related]
23. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
Front Immunol; 2020; 11():1748. PubMed ID: 32849623
[TBL] [Abstract][Full Text] [Related]
24. The amount of cytokine-release defines different shades of Sars-Cov2 infection.
Bindoli S; Felicetti M; Sfriso P; Doria A
Exp Biol Med (Maywood); 2020 Jun; 245(11):970-976. PubMed ID: 32460624
[TBL] [Abstract][Full Text] [Related]
25. Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs.
Scala S; Pacelli R
Front Immunol; 2020; 11():1201. PubMed ID: 32574268
[TBL] [Abstract][Full Text] [Related]
26. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.
Jouan Y; Guillon A; Gonzalez L; Perez Y; Boisseau C; Ehrmann S; Ferreira M; Daix T; Jeannet R; François B; Dequin PF; Si-Tahar M; Baranek T; Paget C
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32886755
[TBL] [Abstract][Full Text] [Related]
27. The pandemic COVID-19: a tale of viremia, cellular oxidation and immune dysfunction.
Rowaiye AB; Onuh OA; Oli AN; Okpalefe OA; Oni S; Nwankwo EJ
Pan Afr Med J; 2020; 36():188. PubMed ID: 32952832
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
29. Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients.
Convertino I; Tuccori M; Ferraro S; Valdiserra G; Cappello E; Focosi D; Blandizzi C
Crit Care; 2020 Jun; 24(1):331. PubMed ID: 32527304
[TBL] [Abstract][Full Text] [Related]
30. [Acute respiratory distress syndrome secondary to SARS-CoV-2 infection in an infant].
Lahfaoui M; Azizi M; Elbakkaoui M; El Amrani R; Kamaoui I; Benhaddou H
Rev Mal Respir; 2020 Jun; 37(6):502-504. PubMed ID: 32471720
[No Abstract] [Full Text] [Related]
31. Cytokine storm induced by SARS-CoV-2.
Song P; Li W; Xie J; Hou Y; You C
Clin Chim Acta; 2020 Oct; 509():280-287. PubMed ID: 32531256
[TBL] [Abstract][Full Text] [Related]
32. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in".
Castelli V; Cimini A; Ferri C
Front Immunol; 2020; 11():2132. PubMed ID: 32983172
[TBL] [Abstract][Full Text] [Related]
33. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.
Morris G; Bortolasci CC; Puri BK; Olive L; Marx W; O'Neil A; Athan E; Carvalho AF; Maes M; Walder K; Berk M
Life Sci; 2020 Oct; 258():118166. PubMed ID: 32739471
[TBL] [Abstract][Full Text] [Related]
34. A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections.
Orlov M; Wander PL; Morrell ED; Mikacenic C; Wurfel MM
J Immunol; 2020 Aug; 205(4):892-898. PubMed ID: 32651218
[TBL] [Abstract][Full Text] [Related]
35. A rationale for targeting the P2X7 receptor in Coronavirus disease 19.
Di Virgilio F; Tang Y; Sarti AC; Rossato M
Br J Pharmacol; 2020 Nov; 177(21):4990-4994. PubMed ID: 32441783
[TBL] [Abstract][Full Text] [Related]
36. Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
Pickles OJ; Lee LYW; Starkey T; Freeman-Mills L; Olsson-Brown A; Cheng V; Hughes DJ; Lee A; Purshouse K; Middleton G
Br J Cancer; 2020 Sep; 123(5):691-693. PubMed ID: 32546835
[TBL] [Abstract][Full Text] [Related]
37. Brainstem Dysfunction in SARS-COV-2 Infection can be a Potential Cause of Respiratory Distress.
Machado C; DeFina PA; Chinchilla M; Machado Y; Machado Y
Neurol India; 2020; 68(5):989-993. PubMed ID: 33109839
[TBL] [Abstract][Full Text] [Related]
38. COVID-19: Melatonin as a potential adjuvant treatment.
Zhang R; Wang X; Ni L; Di X; Ma B; Niu S; Liu C; Reiter RJ
Life Sci; 2020 Jun; 250():117583. PubMed ID: 32217117
[TBL] [Abstract][Full Text] [Related]
39. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection.
Lavi E; Cong L
Exp Mol Pathol; 2020 Aug; 115():104474. PubMed ID: 32454103
[TBL] [Abstract][Full Text] [Related]
40. Cancer and COVID-19: Unmasking their ties.
Addeo A; Friedlaender A
Cancer Treat Rev; 2020 Aug; 88():102041. PubMed ID: 32516704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
